Enhanced surveillance and investigation of coronavirus: What is required?

Eastern Mediterranean Health Journal

Volumn 19, Issue SUPPL.1, 2013, Pages 55-60

  Pebody, R G ^a   Nicoll, A ^b   Buchholz, U ^c   Zambon, M ^a   Mounts, A ^d  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c ROBERT KOCH INSTITUTE   (Germany)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CORONAVIRUS INFECTION; DISEASE SURVEILLANCE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PERSONNEL; HUMAN; INFECTION PREVENTION; NONHUMAN; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; PUBLIC HEALTH SERVICE; RESPIRATORY DISTRESS; RISK FACTOR; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; VIROLOGY; VIRUS DETECTION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 84922687389     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2013.19.supp1.s55     Document Type: Article

References (18)

1. Zaki AM et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New England Journal of Medicine, 2012, 367:1814-1820.
2. Bermingham A et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Eurosurveillance, 2012, 17(40):pii 20290.
3. Pebody RG et al. The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Eurosurveillance, 2012, 17(40):pii 202922.
4. Nicoll A. Public health investigations required for protecting the population against novel coronaviruses. Eastern Mediterranean Health Journal, 2013, 19(Suppl.):S61-S67.
5. Langmuir AD. The surveillance of communicable diseases of national importance. New England Journal of Medicine, 1963, 268:182-192.
6. International health regulations (2005), 2nd ed. Geneva, World Health Organization, 2005.
7. Heymann D, Mackenzie J, Peiris M. SARS legacy: outbreak reporting is expected and respected. Lancet, 2013, 381:779-781.
8. Corman VM et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Eurosurveillance, 2012, 17(39):pii 20285.
9. Interim surveillance recommendations for human infection with novel coronavirus (28 November 2012). Geneva, World Health Organization, 2012 (http://www.who.int/csr/disease/coronavirus_infections/InterimRevisedSurveillanceRecommendations_nCoVinfection_20121128.pdf, accessed 6 May 2013).
10. Coronavirus. Update, case definitions, and guidance. Centers for Disease Control and Prevention [online factsheet] (http:// www.cdc.gov/coronavirus/ncv/case-def.html#case, accessed 6 May 2013).
11. The first few hundred (FF100). Enhanced case and contact protocol v4.0. Epidemiological protocols for comprehensive assessment of early novel coronavirus cases and their close contacts in the United Kingdom. London, Health Protection Agency, 2012 (http://www.hpa.org.uk/webc/HPAwebFile/ HPAweb_C/131713630080, accessed 6 May 2013).
12. Schwere respiratorische Erkrankungen in Verbindung mit einem Neuartigen Coronavirus. Falldefinition zur Fallfindung, Meldung und Übermittlung. Aktualisierte Version vom 12.12.201 [Severe respiratory disease in conjunction with a novel coronavirus. Case definition for case finding, reporting and communication. Updated version 12.12.201]. Berlin, Robert Koch Institute, 2012 (http:// www.rki.de/DE/Content/InfAZ/C/Corona/Corona_Falldefinition.pdf?__blob=publicationFile, accessed 6 May 2013).
13. Rapid risk assessment. Severe respiratory disease associated with a novel coronavirus. 19 February 2013. Stockholm, European Centre for Disease Control and Prevention, 2013 (http://www. ecdc.europa.eu/en/publications/Publications/novel-coronavirus-rapid-risk-assessment-update.pdf, accessed 6 May 2013).
14. Health Protection Agency (HPA) UK NCoV Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Eurosurveillance, 2013, 18(11):pii 20427.
15. Buchholz U et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Eurosurveillance, 2013, 18(8):pii 20406.
16. Novel coronavirus infection-update. 8 May 2013. World Health Organization [online] (http://www.who.int/csr/disease/ coronavirus_infections/update_20130508/en/index.html, accessed 8 May 2013).
17. Peiris JS et al. The severe acute respiratory syndrome. New England Journal of Medicine, 2003, 349:2431-2441.
18. Van Kerkhove M et al. The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy. Influenza and Other Respiratory Viruses, 2013, 7(3):231-234.